ICD-10-CM T45.605: Adverse effect of unspecified fibrinolysis-affecting drugs

ICD-10-CM Diagnosis Code (2025)

Official Description for T45.605

Adverse effect of unspecified fibrinolysis-affecting drugs

Parent Code (Less Specific):

About ICD-10-CM Code T45.605 (Adverse effect of unspecified fibrinolysis-affecting drugs)

ICD-10-CM code T45.605 is a billable or specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM T45.605 became effective on October 1, 2024.

This page provides detailed information about T45.605 - Adverse effect of unspecified fibrinolysis-affecting drugs. It includes common terminology, coding guidelines such as "Includes," "Excludes1," and "Excludes2" notes, and information on required 7th characters. Utilizing this information correctly is essential for accurate medical coding and claims submission for conditions like Adverse effect of unspecified fibrinolysis-affecting drugs.